Inspire Medical Systems, Inc. announced that it has received approval from the Food and Drug Administration (FDA) on an expanded indication. The update includes an increase on the upper limit of the Apnea-Hypopnea Index (AHI) to 100 events per hour from 65 and raises the Body Mass Index (BMI) warning […]
Tag: AHI
Novel Cannabinoid Combo Shows Promise for OSA Treatment
Incannex Healthcare Limited (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, is pleased to announce that it has completed analysis of data from the Phase 2 proof-of-concept clinical trial investigating IHL-42X for treatment of obstructive sleep […]
Siesta Medical’s AIRLIFT® Hyoid Suspension Study Shows 74% Reduction in AHI
Siesta Medical, Inc. announced the online publication of a recent study of the AIRLIFT procedure titled “Hyoid Suspension With UPPP for the Treatment of Obstructive Sleep Apnea” in the Ear, Nose & Throat Journal. This multicenter study evaluated the safety and efficacy of AIRLIFT hyoid suspension when combined with procedures for […]
Study Identifies Increased Residual Sleep-Disordered Breathing in Patients on CPAP
By Lindsey Nolen A common misconception across sleep medicine is that continuous positive airway pressure (CPAP) machines fully resolve sleep-disordered breathing (SDB) in apnea patients showing a successful AHI. However, research has shown that residual SDB can still occur during the use of a CPAP machine, leading to the need […]
Nox Medical Launches Nox T3s Featuring Innovative Nox BodySleep Analysis
Nox Medical, the sleep medical device branch of Nox Health, has revolutionized home sleep testing with the launch of its newest device, the Nox T3s. The Nox T3s is based on the world-renowned Nox T3, which launched in 2009 and quickly became, for many, the standard for home sleep testing. […]








